Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat
CCTA has emerged as the preferred non-invasive modality for the study of chest pain due to possible underlying CAD, and for the assessment of cardiovascular risk. Technical advances and realignment of patient pathways make CCTA a first-line investigation for assessment of CAD.Perivascular fat attenuation is a novel biomarker of coronary artery inflammation that can be evaluated from routine CCTA. It has the potential to predict coronary risk, above and beyond plaque features or stenosis, and is able to reclassify a substantial proportion of patients.
Read more
March 2023
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy
In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more…
Read more
March 2023
Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk
JACC Review Topic of the Week. In this review the authors aim to summarize the role of PCAT in cardiac…